The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis

BACKGROUND: Several countries paused their rollouts of the Oxford-AstraZeneca coronavirus disease-19 (COVID-19) vaccine in mid-March 2021 due to concerns about vaccine-induced thrombosis and thrombocytopenia. Many warned that this risked damaging public confidence during a critical period of pandemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Vageesh, Lorgelly, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Covid 19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341841/
https://www.ncbi.nlm.nih.gov/pubmed/35394507
http://dx.doi.org/10.1093/eurpub/ckac039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341841/
https://www.ncbi.nlm.nih.gov/pubmed/35394507
http://dx.doi.org/10.1093/eurpub/ckac039

Ejemplares similares